Results from the Oxford/AstraZeneca phase 3 vaccine trial are expected by the end of the month. Hopes are high following the announcement that a second
I read somewhere the other day that the problem with the European Union was that its best days were behind it; loath though I am
In the most encouraging development since dexamethasone was found to slash mortality rates in seriously ill coronavirus patients, interim results from a large-scale Pfizer/BioNTech trial
In anticipation of an effective vaccine, the challenge of finding Covid-19 treatments has proven to be considerable. And while there are encouraging signs that a
Finally, some good news. The prospect of life returning to something like normality is now closer than ever before after interim results from a large-scale
Some of Britain’s biggest companies – Sainsbury’s, John Lewis and Lloyds Bank – announced they were axing another few thousand jobs today amid fresh warnings
Editor of Reaction Iain Martin interviews leading epidemiologist and lockdown sceptic Professor Sunetra Gupta. They discuss Boris Johnson’s decision to impose a new lockdown in
Last week, Spain became the first European country to record 1 million Coronavirus cases, a truly unwelcome milestone. Faced with a second wave of the
Earlier this month, three of the world’s leading epidemiologists published a short treatise, which reflected their concerns about the physical, mental and financial impacts of
Subscribe to Reaction and receive unlimited access to the site, our daily email with analysis every evening and invites to online events.
© Copyright 2024 Reaction Digital Media Limited – All Rights Reserved. Registered Company in England & Wales – Company Number: 10166531.
